C12N 2710/18011
Nimaviridae
C12N2710/18011 (Nimaviridae) appears on 26 US grants and 47 published applications in this corpus.
Search patents in C12N- Granted patents
- 26
- Published applications
- 47
- Assignees
- 31
- Inventors
- 79
- Latest grant
- 23 Apr 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 3 |
| 2004 | 1 | 2 |
| 2005 | 2 | 2 |
| 2006 | 1 | 1 |
| 2007 | 0 | 3 |
| 2008 | 2 | 1 |
| 2009 | 1 | 5 |
| 2010 | 1 | 1 |
| 2011 | 2 | 2 |
| 2012 | 2 | 3 |
| 2013 | 0 | 3 |
| 2014 | 3 | 7 |
| 2015 | 1 | 2 |
| 2016 | 1 | 1 |
| 2017 | 1 | 3 |
| 2018 | 1 | 0 |
| 2019 | 0 | 3 |
| 2020 | 4 | 2 |
| 2021 | 1 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2710/18022New viral proteins or individual genes, new structural or functional aspects ofIndexing code18
- C12N 2710/18034Use of virus or viral component as vaccineIndexing code14
- C12N 2710/18041Use of virus, viral particle or viral elements as a vectorIndexing code2
- C12N 2710/18051Methods of production or purification of viral materialIndexing code1
- C12N 2710/18021Viruses as suchIndexing code0
- C12N 2710/18023Virus like particles [vlp]Indexing code0
- C12N 2710/18031Uses of virus other than therapeutic or vaccineIndexing code0
- C12N 2710/18032Use of virus as therapeutic agent, other than vaccineIndexing code0
Recent patents
- Process for T cell expansion23 Apr 2024US 11,963,979 B2AlloVir, Inc.
- Edible vaccines expressed in yeast for preventing and treating infectious diseases in animals and human31 Aug 2021US 11,103,571 B2
- DNA constructs for manufacturing bio-therapuetic polypeptides for use in animal vaccines and therapeutics24 Nov 2020US 10,844,382 B2MicroSynbiotiX, Ltd.
- System for the biocontrol of pathogens in aquaculture and other animal systems15 Sep 2020US 10,774,329 B2Pebble Labs USA Inc.
- Edible vaccines expressed in yeast for preventing and treating infectious diseases in animals and humans14 Apr 2020US 10,617,751 B2VisionTech International Limited
- Process for t cell expansion12 Feb 2026US 2026/0042987 A1AlloVir, Inc.
- Engineered nodaviral cargo delivery systems26 Sep 2024US 2024/0318202 A1Arizona Board of Regents on Behalf of the University of Arizona
- Process for t cell expansion19 May 2022US 2022/0152111 A1AlloVir, Inc.
- Edible Vaccines Expressed in Yeast for Preventing and Treating Infectious Diseases in Animals and Human12 Nov 2020US 2020/0353066 A1Poly Tech Services Limited
- Novel System for the Biocontrol of Pathogens in Aquaculture and Other Animal Systems30 Jan 2020US 2020/0032267 A1Pebble Labs USA Inc.
Most cited
By later US patents
- System and method for measuring animals128US 8,036,429 B22011
- Cell line derived from Penaeus monodon and a method of growing virus using the same52US 6,143,547 AAcademia Sinica · 2000
- Transgenic algae for delivering antigens to an animal27US 7,410,637 B2Phycotransgenics L.L.C. · 2008
- System and method for measuring animals23US 7,128,024 B22006
- Antigenic proteins of shrimp white spot syndrome virus and uses thereof6US 6,908,616 B2Akzo Nobel N. V. · 2005